Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-28T06:08:05.205Z Has data issue: false hasContentIssue false
  • English
  • Français

State-of–the-Art Management of Hypertrophic Cardiomyopathy in Children

Published online by Cambridge University Press:  01 November 2009

Stuart Berger ,
Anwer Dhala  and
Joseph A. Dearani
Stuart Berger*
Affiliation:
Professor of Pediatrics, The Medical College of Wisconsin, Milwaukee, Wisconsin
Anwer Dhala
Affiliation:
Professor of Pediatrics, The Medical College of Wisconsin, Milwaukee, Wisconsin
Joseph A. Dearani
Affiliation:
Professor of Surgery, Mayo Clinic School of Medicine
*
Correspondence to: Stuart Berger, MD, Professor of Pediatrics, Children’s Hospital of Wisconsin-Herma Heart Center, 9000 W. Wisconsin Avenue, Milwaukee, Wisconsin 53226. 414-266-2434 (office); 414-266-2294 (fax); E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Cardiomyopathyleft ventricular hypertrophymyomectomy
Type
Original Article
Information
Cardiology in the Young , Volume 19 , Issue S2: Innovation associated with the treatment of patients with congenital and pediatric cardiac disease , November 2009 , pp. 66 - 73
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Maron, BJ. Hypertrophic cardiomyopathy in childhood. In Pediatric Clinics of North America 51 (2004): 1305–1346.CrossRefGoogle Scholar
2.Ganame, J, Pignatelli, RH, Eidem, BW, et al. Myocardial deformation abnormalities in pediatric hypertrophic cardiomyopathy: are all etiologies identical? Eur J Echocardiogr 2008; 9 (6): 784–790; Epub 2008 Apr 27.CrossRefGoogle ScholarPubMed
3.Morita, H, Rehm, HL, Mennices, A. Shared genetic causes of cardiac hypertrophy in children and adults. NEJM 2008; 358 (18): 1899–1908; Epub 2008 Apr 9.CrossRefGoogle ScholarPubMed
4.Bos, JM, Ommen, SR, Ackerman, MJ. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases? Curr Opinion Cardiol 2007; 22 (3): 193–199.CrossRefGoogle ScholarPubMed
5.Maron, BJ, Casey, SA, Poliac, LC, et al. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999: 281–650–655.Google Scholar
6.Maron, BJ. Echocardiographic assessment of left ventricular hypertrophy in patients with obstructive or nonobstructive hypertrophic cardiomyopathy. Eur Heart J 1983; 4 Suppl F: 73–91.CrossRefGoogle ScholarPubMed
7.Rawlins, J, Bahn, A, Sharma, S. Left ventricular hypertrophy in athletes. Eur J Echocardiograph 2009; 10 (3): 350–356; Epub 2009 Feb 26.CrossRefGoogle ScholarPubMed
8.Maron, BJ, Spirito, P, Wesley, , et al. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. NEJM 1986; 315: 610–614.CrossRefGoogle ScholarPubMed
9.Maron, BJ, Seidman, JG, Seidman, CE. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 44 (11): 2125–2132.CrossRefGoogle ScholarPubMed
10.Maron, MS, Olivotto, I, Betochhi, S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. NEJM 2003; 348: 295–303.CrossRefGoogle ScholarPubMed
11.Poutanen, T, Tikanoja, T, Jaaskelainen, P. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beta-myosin heavy chain, alpha-tropomyosin, and myosin-binding protein C genes. Am Heart J 2006; 151 (3): 725.e1–725.e9.CrossRefGoogle ScholarPubMed
12.Sotgia, B, Sciagra, R, Olivotto, I, et al. Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy. J Nucl Med 2008; 49 (7): 1090–1096.CrossRefGoogle ScholarPubMed
13.Sherrid, MV, Barac, I, McKenna, WJ, et al. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 45 (8): 1252–1258.CrossRefGoogle ScholarPubMed
14.Koffland, MJ, Waldstein, DJ, Vos, J, ten Cate, FJ. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am J Cardiol 1993; 72: 939–943.CrossRefGoogle Scholar
15.Maron, BJ, Olovetto, I, Spirito, P, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 2000; 102: 858–864.CrossRefGoogle Scholar
16.Maron, BJ, Shen, WK, Link, MS, et al. Efficiacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. NEJM 2000; 342: 363–373.CrossRefGoogle Scholar
17.Elliott, PM, Poloniecki, J, Dickie, S, et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000; 36: 2212–2218.CrossRefGoogle ScholarPubMed
18.Spirito, P, Seidman, CE, McKenna, WJ, Maron, BJ. Management of hypertrophic cardiomyopathy. NEJM 1997; 336: 775–785.CrossRefGoogle ScholarPubMed
19.Ostman-Smith, I, Wettrell, G, Riesenfeld, T. A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta adrenoceptor antagonisy treatment. J Am Coll Cardiol 1999; 34: 1813–1822.CrossRefGoogle ScholarPubMed
20.Cairns, JA, Connolly, SJ, Roberts, R, et al. Randomized trial of outcome after myocardial infarction I patients with frequent or repetitive ventricular premature depolarizations: CAMIAT. Lancet 1997; 349: 675–682.CrossRefGoogle ScholarPubMed
21.Julian, DJ, Camm, AJ, Frangin, GA, et al. Randomized trial of effect of amiodarone on mortalityt in patients with left ventricular dysfunction after recent myocardial infarction: AMIAT. Lancet 1997; 349: 667–674.CrossRefGoogle Scholar
22.Moss, AJ, Hall, WJ, Cannom, DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for arrhythmia. NEJM 1996; 335: 1933–1940.CrossRefGoogle ScholarPubMed
23.Silka, MJ, Kron, J, Dunnigan, A, Dick, M. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. Circulation 1993; 87: 800–807.CrossRefGoogle ScholarPubMed
24.Elliott, PM, Sharma, S, Varnava, A, et al. Survival after cardiac arrest in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999; 33: 1596–1601.CrossRefGoogle ScholarPubMed
25.Berul, CI, Van Hare, GF, Kertesz, NJ, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008; 51: 1685–1691.CrossRefGoogle ScholarPubMed
26.Nishimura, RA, Giuliani, ER, Brandenburg, RO, et al. Hypertrophic cardiomyopathy. Mayo Clinic Practice of Cardiology, 3rd Edition Chapter 20. In: Giuliani ER, Gersh BJ, McGoon MD, Hayes DL, Schaff HV (eds). Mosby-Year Book Inc., St. Louis, MO, 1996, pp 689–711.Google Scholar
27.Theodoro, DA, Danielson, GK, Feldt, RH, Anderson, BJ. Hypertrophic obstructive cardiomyopathy in pediatric patients: Results of surgical treatment. J Thorac Cardiovasc Surg 1996; 112: 1589–1599.CrossRefGoogle ScholarPubMed
28.Maron, BJ, McKenna, WJ, Danielson, GK, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the ACC Task Force on Clinical Expert Consensus Documents and the Committee to Develop an Expert Consensus Document on Hypertrohic Cardiomyopathy. J Am Coll Cardiol 2003; 42: 1687–1713.CrossRefGoogle Scholar
29.Maron, BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 287: 1308–1320.CrossRefGoogle ScholarPubMed
30.Dearani, JA, Danielson, GK. Septal myectomy for hypertrophic cardiomyopathy. Operative Techniques in Thoracic and Cardiovascular Surgery 2004; 9: 278–292.CrossRefGoogle Scholar
31.McKenna, WJ, Deanfield, J, Faruqui, A, et al. Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981; 47: 532–538.CrossRefGoogle ScholarPubMed
32.Minakata, K, Dearani, JA, O’Leary, PW, et al. Septal myectomy for obstructive hypertrophic cardiomyopathy in pediatric patients: early and late results. Ann Thorac Surg 2005; 80: 1424–1430.CrossRefGoogle ScholarPubMed
33.McCully, RB, Nishimura, RA, Tajik, AJ, et al. Extent of clinical improvement after surgical treatment of hypertrophic cardiomyopathy. Circulation 1996; 94: 467–471.CrossRefGoogle Scholar
34.Seiler, C, Hess, OM, Schoenbeck, M, et al. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol 1991; 17: 634–645.CrossRefGoogle ScholarPubMed
35.Ommen, SR, Maron, BJ, Olivotto, I, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 46 (3): 470–476.CrossRefGoogle ScholarPubMed
36.Minaka, K, Dearani, JA, Nishimura, RA, et al. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous papillary muscles or chordae. J Thorac Cardiovasc Surg 2004; 127: 481.CrossRefGoogle Scholar